BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23222305)

  • 1. TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.
    Weiss MB; Abel EV; Mayberry MM; Basile KJ; Berger AC; Aplin AE
    Cancer Res; 2012 Dec; 72(24):6382-92. PubMed ID: 23222305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CADM1 is a TWIST1-regulated suppressor of invasion and survival.
    Hartsough EJ; Weiss MB; Heilman SA; Purwin TJ; Kugel CH; Rosenbaum SR; Erkes DA; Tiago M; HooKim K; Chervoneva I; Aplin AE
    Cell Death Dis; 2019 Mar; 10(4):281. PubMed ID: 30911007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation.
    Crowe MS; Zavorotinskaya T; Voliva CF; Shirley MD; Wang Y; Ruddy DA; Rakiec DP; Engelman JA; Stuart DD; Freeman AK
    Mol Cancer Res; 2021 Jun; 19(6):1063-1075. PubMed ID: 33707308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
    Huntington JT; Shields JM; Der CJ; Wyatt CA; Benbow U; Slingluff CL; Brinckerhoff CE
    J Biol Chem; 2004 Aug; 279(32):33168-76. PubMed ID: 15184373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
    Ding X; Li F; Zhang L
    Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.
    Weiss MB; Abel EV; Dadpey N; Aplin AE
    Mol Cancer Res; 2014 Sep; 12(9):1314-23. PubMed ID: 25061102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
    Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
    Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
    Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
    Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
    Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
    Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells.
    Katiyar P; Aplin AE
    Mol Cancer Res; 2011 May; 9(5):545-52. PubMed ID: 21478267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.
    Blackburn JS; Liu I; Coon CI; Brinckerhoff CE
    Oncogene; 2009 Dec; 28(48):4237-48. PubMed ID: 19734937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
    Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
    Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.